← Leaderboards
William J Rogers
University Of Alabama At Birmingham
$1,250,435
Attributed
$1,250,435
Total exposure
9
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $53.7K · FY2005–07$100K$75K$50K$25K$0
'05
'06
'07
Funding mix
By agency
NIH$1,250,435 · 9
By mechanism
M01$1,005,798 · 7
N01$244,637 · 2
Top collaborators
No co-investigators on record.
Most similar at University Of Alabama At Birmingham
Same institution · by research overlap
- Raymond E. Ideker$11,606,941
- Gerald Michael Pohost$6,462,218
- Michelle L Robbin$806,802
- Jeroan J Allison$7,989,159
- Diane M Grimley$2,615,232
Others in their field
Top investigators on “Human Subject”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- George R Seage · Abt Associates, Inc.$172,422,660
- Jay Arnold Tischfield · Rutgers, The State Univ Of N.J.$160,455,836
- Jeffrey P Krischer · University Of South Florida$155,493,283
- Charles A Coltman · Southwest Oncology Group$154,811,913
Research focus
Human SubjectClinical ResearchHuman Therapy EvaluationFemaleHormone TherapyCoronary DisorderAngiographyWomen'S HealthCardiovascular Disorder ChemotherapyCardiovascular Disorder PreventionHeart Disorder DiagnosisEstrogensDrug Screening /EvaluationMyocardial Ischemia /HypoxiaDiagnosis Design /EvaluationPostmenopauseClinical TrialsAscorbateCoronary ArteryMethod DevelopmentHuman MortalityCongestive Heart FailureBeta Antiadrenergic AgentCombination Chemotherapy
Grant awards (19)
BARI 2D STUDY$50,653
M01 · FY2007 · RR · contact PI
BARI 2D STUDY$48,175
M01 · FY2006 · RR · contact PI
BYPASS ANGIOPLASTY REVASCULARIZATION INVESTIGATION 2 DIABETES (BARI 2D) STUDY$53,712
M01 · FY2005 · RR
Bypass angioplasty revascularization invest. 2 diabetes$63,647
M01 · FY2004 · RR
WOMENS ANGIOGRAPHIC VITAMIN &ESTROGEN (WAVE) TRIAL$175,256
M01 · FY2002 · RR
WOMENS ISCHEMIC SYNDROME EVALUATION$175,256
M01 · FY2002 · RR
BETA BLOCKER EVALUATION OF SURVIVAL TRIAL$0
M01 · FY2002 · RR
WOMENS ISCHEMIC SYNDROME EVALUATION$175,256
M01 · FY2001 · RR
WOMENS ANGIOGRAPHIC VITAMIN &ESTROGEN (WAVE) TRIAL$175,256
M01 · FY2001 · RR
BETA BLOCKER EVALUATION OF SURVIVAL TRIAL$0
M01 · FY2001 · RR
CLINICAL UNIT FOR THE ANGIOGRAPHIC TRIAL IN WOMEN$0
N01 · FY2001 · HV
ISCHEMIC HEART DISEASE IN WOMEN-CLINICAL CENTER$244,637
N01 · FY2000 · HV
BETA BLOCKER EVALUATION OF SURVIVAL TRIAL$29,529
M01 · FY2000 · RR
WOMENS ISCHEMIC SYNDROME EVALUATION$29,529
M01 · FY2000 · RR
WOMENS ANGIOGRAPHIC VITAMIN &ESTROGEN (WAVE) TRIAL$29,529
M01 · FY2000 · RR
ESTROGEN REPLACEMENT AND ATHEROSCLEROSIS (ERA) TRIAL$0
M01 · FY2000 · RR
BYPASS ANGIOPLASTY REVASCULARIZATION INVESTIGATION BARI$0
M01 · FY2000 · RR
CLINICAL UNIT FOR THE ANGIOGRAPHIC TRIAL IN WOMEN$0
N01 · FY2000 · HV
AZITHROMYCIN AND CORONARY EVENTS STUDY (ACES)$0
M01 · FY2000 · RR